Determination of Meloxicam Using Direct and Indirect Flow Injection Spectrophotometry

Author(s): Ream Ismail Abed, Hind Hadi*

Journal Name: Current Pharmaceutical Analysis

Volume 17 , Issue 2 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Meloxicam is a non-steroidal anti-inflammatory drug, known to inhibit cyclooxygenase, a key enzyme of prostaglandin biosynthesis at the site of inflammation.

Objectives: Two sensitive and fast spectrophotometric methods (direct and indirect) using flOW INJection Analysis (FIA) have been described for the assay of meloxicam in pure and in pharmaceutical formulations.

Methods: The direct method (method A) depended on the coupling of meloxicam with diazotized procaine benzylpenicillin in alkaline medium. In contrast, the indirect method (method B) involved a charge transfer reaction between the alkaline hydrolytic product of meloxicam as n-donor with metol (p-methylaminophenol sulfate) as a π- acceptor using sodium periodate as an oxidant.

Results: The colored products exhibited absorption maxima at 492 and 656 nm for method A and B respectively. The methods obeyed Beer’s low over concentration ranges of 5-80 and 15-225 μg/mL, respectively. The detection limits were 2.73 and 5.26 μg/mL for direct and indirect methods, respectively. The chemical and physical parameters associated with FIA manifolds were optimized to construct the most sensitive and reproducible results.

Conclusion: Methods described herein are cheap, environmentally friendly and showed no significant difference with those of the official method indicated no significant difference in accuracy and precision.

Keywords: Meloxicam, procaine benzylpenicillin, diazotization reaction, charge transfer reaction, metol, flow injection.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 2
Year: 2021
Published on: 25 January, 2021
Page: [254 - 264]
Pages: 11
DOI: 10.2174/1573412916666200224103731
Price: $65

Article Metrics

PDF: 7